Artiva Biotherapeutics In... (ARTV)
NASDAQ: ARTV
· Real-Time Price · USD
6.01
3.24 (116.97%)
At close: Oct 17, 2025, 3:59 PM
5.48
-8.82%
After-hours: Oct 17, 2025, 05:29 PM EDT
Artiva Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 251K | 33.49M | 4.93M | 2M |
Cost of Revenue | n/a | n/a | n/a | n/a |
Gross Profit | 251K | 33.49M | 4.93M | 2M |
Operating Income | -67.28M | -30.67M | -59.83M | -53.27M |
Interest Income | 5.35M | 2.54M | 1.29M | n/a |
Pretax Income | -58.49M | -27.62M | -58.34M | -71.83M |
Net Income | -58.49M | -27.7M | -58.39M | -71.83M |
Selling & General & Admin | 17.2M | 13.91M | 20.78M | 12.86M |
Research & Development | 50.33M | 50.25M | 43.98M | 42.41M |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 67.53M | 64.16M | 64.76M | 55.27M |
Interest Expense | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 67.53M | 64.16M | 64.76M | 55.27M |
Income Tax Expense | n/a | 72K | 53K | n/a |
Shares Outstanding (Basic) | 11.26M | 23.28M | 17.58M | 17.58M |
Shares Outstanding (Diluted) | 11.26M | 23.28M | 17.58M | 17.58M |
EPS (Basic) | -5.2 | -1.19 | -3.32 | -4.08 |
EPS (Diluted) | -5.2 | -1.19 | -3.32 | -4.08 |
EBITDA | -64.85M | -28.41M | -58.67M | -71.58M |
EBIT | -67.28M | -30.67M | -59.83M | -71.83M |
Depreciation & Amortization | 2.43M | 2.27M | 1.16M | 248K |
Source: Financial Modeling Prep. Financial Sources.